Ventilator Associated Pneumonia Compounds The Risks Of Critically Ill Patients Face
1341 Words6 Pages
Ventilator-associated pneumonia compounds the risks that critically-ill patients face in hospitalization. It affects a high proportion of patients on ventilators and has a fluctuating morbidity rate. The goal of this paper is to demonstrate the potential usefulness of chlorhexidine in preventing ventilator-associated pneumonia in adults. The paper features a review of literature found via MedScape using the keywords “chlorhexidine,” “ventilator-associated pneumonia,” “long-term ventilation” and “prevention.” The results show that there is a positive correlation between using chlorhexidine in the oral care of patients using a ventilator; however, the evidence thus far does not present an opportunity to promote any clinical recommendations.…show more content… This literature review will look to see whether critical care patients (P) can benefit from chlorhexidine treatment (I) as compared to tradition oral care (C) to prevent ventilator-associated pneumonia (O) during the patients stay in the hospital (T). The literature demonstrates a potential link between chlorhexidine treatment, oral health care and a potential reduction in the number of cases and ventilator-associated pneumonia, ultimately recommending further studies.
Literature Search The literature found in this study was found by searching for relevant papers on MedScape. The keywords “chlorhexidine,” “ventilator-associated pneumonia,” “long-term ventilation” and “prevention.”
In a trial by Arti et al, researchers used chlorhexidine to attempt to prevent ventilator-associated pneumonia in children (2013). The group included 86 patients who were divided into two groups to complete a double-blind, randomized placebo controlled trial. The first group included 41 children who received 1% chlorhexidine gel every eight hours. The second group included 45 children who received a placebo gel. The length of the study was three weeks, or until the patient was extubated. The results demonstrated that 12 of out of the 41 children who received chlorhexidine and 14 out of the 45 placebo patients developed ventilator-associated pneumonia. The results showed that there was no clear reduction in the occurrence of pneumonia